Henrik Von Tangen-Jordan

B. 2001 | 1341 SLEPENDEN

Share Ownership

Direct Ownership

20.00%(200)200 shares

Indirect Ownership

0.32%

0.18%

0.14%

TERNINGEN INVEST AS

0.14%

VESTBYLOG INVEST AS

0.10%

TELEGRAFEN INVEST AS

0.10%

0.09%

HADEAN CAPITAL I AS

0.08%

LYTIX BIOPHARMA AS

0.08%

0.06%

GENETIC ANALYSIS AS

0.06%

HELSFYR KONTORINVEST III AS

0.04%

PHARMA HOLDINGS AS

0.04%

PHARMASUM THERAPEUTICS AS

0.02%

EXACT THERAPEUTICS AS

0.02%

0.01%

PUBLIC PROPERTY INVEST AS

0.01%

RANA GRUBER ASA

0.00%

0.00%

NYKODE THERAPEUTICS ASA

0.00%

SPAREBANK 1 SMN

0.00%

AUSTEVOLL SEAFOOD ASA

0.00%

0.00%

SPAREBANK 1 SR-BANK ASA

0.00%

WALLENIUS WILHELMSEN ASA

0.00%

VÅR ENERGI ASA

0.00%

YARA INTERNATIONAL ASA

Home Industries New Companies About

🇳🇴Norsk 🇬🇧English